| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |